
New data shows cancer treatment waiting times have increased in nearly half of NHS areas this year: see how your trust is performing
Today's figures show that in May the NHS waiting list in England fell, for the third month in a row. There are now 7.36 million outstanding appointments – the lowest level since March 2023.
Health Secretary Wes Streeting welcomed the reduction in the NHS waiting list of 282,000 since Labour took office, down from 7.64 million last July.
Speaking in the Commons, he highlighted the experience of a young cancer patient receiving timely treatment as an example of the difference he says Labour has brought to the NHS.
But not all waiting times are down.
Sky News analysis shows that in nearly half (number in brackets) of 147 NHS trusts with available data fewer people are now being treated for cancer within the target than at the start of the year.
That target is for 85% of cancer patients to begin treatment within two months of their diagnosis.
Only a small number of trusts have achieved this. While 20 trusts met the standard in January, it is down to 15 trusts in May. Performance against the target fell in 62 areas overall between Jan and May, and none of those were meeting the target to begin with.
Among the worst performing trusts are Mid and South Essex, and Hull University Teaching Hospital, with just 42% and 46% of patients beginning treatment within the target time respectively. The biggest increases in waits were in North Cumbria Integrated Care, where the share of people treated within the target period fell from 70% to 50%, and in Liverpool Women's NHS Foundation Trust, the share fell from 44% to just 26%.
It's not only cancer waits where there are big differences in how long you wait for treatment depending on where you access services.
The government has pledged to bring down referral waiting times by 2029, so that no more than 8% patients wait longer than 18 weeks for hospital treatment once they've been referred by a GP.
This has not been achieved in England for a decade, but some areas are doing better than others.
Several trusts are only managing to ensure less than half of their appointments are offered within the time frame, including just 48% at the Countess of Chester Hospital. This compares to the 99.8% of nearly 4,000 patients treated by Kent Community Health within 18 weeks.
Only 13 of the 153 NHS service providers are meeting the target, while many are performing worse than at the start of the year.
The largest decreases were around a 6% decrease in performance, including in Dartford and Gravesham, where performance fell to 60% on target, and in Royal Surrey County Hospital, falling to 55%.
Just over half - 84 - of the trusts are currently managing to complete 60% of appointments within 18 weeks - which is an interim target they are due to meet by March 2026.
Overall, the share of those waiting for longer than 18 weeks has remained mostly static at around 40%. The latest figures show that 39% of the waiting list had been waiting for longer than target in May, compared to 41% in July last year.
In Accident and Emergency, nearly one in four trusts have a greater share of patients waiting for longer than the four-hour target to be seen than in January - despite A&Es tending to be more stretched during winter months. However, performance on this target is better than others overall, and around half of those performing worse are still meeting the target, which is that 95% of patients are seen within four hours of arrival.
To improve and alleviate pressure on hospital services the government says the health service must "reform or die". Labour has set out its vision in a 10-year plan for NHS reform aiming to prioritise community healthcare, shift from late treatment to early intervention, and digitally transform the health service.
But addressing hospital performance and inequalities will be key, Stephen Rock, economist at independent health care thinktank The Health Foundation, told Sky News.
"There is considerable variation across the NHS-particularly post-pandemic. Take delayed discharges, for example: some hospitals discharge patients much faster than others once they're ready to leave. Reducing this variation is essential to maximising the return on NHS investment," he said.
There is no new data available on delayed discharges - where patients are kept for longer than they should be in hospital due to a lack of resource in social care or other services to move them on - as data is only published over winter.
Data from last winter shows that the number of delayed discharges from hospital has barely budged, at just under 14,000 a day on average in January 2025 - with almost identical figures over the past three years.
Thea Stein, chief executive of the Nuffield Trust independent health and social care thinktank, told Sky News that the lack of references to social care in the 10-year plan is "disappointing", as "a proportion of people are stuck in every single hospital in this country because of issues to do with social care and the way in which it is funded," she said.
Social care funding will be addressed separately in a review to be conducted by Dame Louise Casey, which may not reach a conclusion until towards the end of this parliament.
Rising demand and funding challenges
A growing and aging population is one reason demand for healthcare rises every year. Another reason is new technology and treatments, much of which the government is hoping to embrace.
"This is why budgets grow. It isn't purely waste, inefficiency, growing population, and growing ill health," Ms Stein explained.
And while technology offers potential benefits, adopting it is often expensive.
Recent analysis by the Nuffield Trust found that of £22.6bn additional funding between 2023/2024 and 2025/26, 19% will be spent on increased costs of care relating to a growing and aging population, as more people live with health conditions for longer.
Higher demand for new treatments will take up 29% extra funding. The largest cost pressure, however, is inflation-related price rises, including recent pay settlements, which eat into more than half the total uplift in the budget.
Funding allocated to the NHS for day-to-day spending in the latest spending review amounts to a real terms increase of £29bn annually by 2028/29, or a 2.7% rise from 2023/24 levels - the largest uplift for any department.
However, while slightly above the average annual rise for spending reviews since 2010, it is below the 3.3% average increase in the five years leading up to the review, and only slightly higher than average increases from a decade earlier.
And at that time the NHS was not undergoing major reforms.
But the government says that "the era of the NHS's answer always being 'more money, never reform' is over", and that savings made by improving productivity and increasing population health will help them achieve their targets.
The NHS will need to deliver a 2% increase in productivity per year - which means a 2% increase in activity across services from the same level of funding - to meet targets with the funding available. This is more than twice the level that has been achieved in recent years, according to The Health Foundation.
Unexpected shocks - such as upcoming strikes or increasing costs of medicines, could make this more challenging.
The Data and Forensics

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
24 minutes ago
- Daily Mail
Eat to beat bowel cancer - gut doctor reveals SIX hearty snacks to prevent the disease as cases soar in under 50s
A top gut doctor has revealed that one of the simplest ways to cut your risk of bowel cancer could be sitting in your fridge—and it's not just about loading up on fibre. Dr Joseph Salhab says while the digestion-boosting nutrient plays a key role in preventing the disease, it's not the whole story. 'Remember that lowering your risk is not the same as eliminating your risk, but we know people with healthier diet have a lower risk of chronic disease,' he said. One easy way to tip the odds in your favour? Eat a daily portion of yoghurt. The dairy favourite, which contains naturally occurring cancer-fighting bacteria, could reduce bowel cancer risk by as much as 20 per cent, if eat daily, experts have claimed. Dr Salhab, whose Instagram video on the topic has been viewed over 1.4 million times, also recommends adding a handful of nuts to your breakfast. Tree nuts like almonds, hazelnuts and walnuts are packed with fibre, protein and omega-3 fats—all linked to a reduced risk of heart disease, type 2 diabetes, stroke and bowel cancer. But of course, fibre does play an important role too. According to Bowel Cancer UK, a lack of fibre—the indigestible parts of plants that support digestion—is responsible for an alarming 28 per cent of all bowel cancer cases in the UK. Often called roughage, fibre helps maintain a healthy gut by supporting regular bowel movements and reducing the time potential toxins remain in contact with the bowel wall. And Dr Salhab didn't stop there when it comes to easy breakfast swaps that can help ward off disease. According to the gut expert, an apple a day really can keep the doctor away—potentially slashing the risk of colorectal cancer by 47 per cent. Kiwis may be even more powerful. Just one serving provides over 80 per cent of an adult's daily vitamin C needs, and they're rich in antioxidants and phytochemicals that help the body neutralise free radicals—unstable molecules linked to cancer, heart disease and diabetes. Mr Haney Youssef, a colorectal surgeon at The Harborne Hospital in Birmingham, told the Daily Mail earlier this week that fruits high in fibre are crucial for maintaining gut health. He said: 'When beneficial bacteria in our gut ferment fibre, they produce short-chain fatty acids like butyrate. 'These compounds actually nourish the cells lining our bowel and have anti-inflammatory properties that help prevent the cellular changes that can lead to cancer.' And it's not just breakfast foods that offer protection. Snacks like guacamole and salsa can also benefit the digestive tract, according to Dr Salhab. Avocados are rich in phytonutrients with proven cancer-fighting properties and are a good source of healthy fats, which may help guard against colon cancer. Tomatoes, meanwhile, are one of the few major sources of lycopene—a powerful antioxidant shown to reduce the risk of digestive tract cancers, according to the American Institute for Cancer Research. But Dr Salhab stressed that while a healthy diet can lower the risk of chronic diseases such as cancer, 'diet never replaces medical therapy or evaluation.' He urged anyone concerned about changes in their bowel habits to speak to their GP. Common warning signs include persistent changes in bowel movements—such as diarrhoea, constipation, or going more or less often—as well as blood in the stool, abdominal pain, unexplained weight loss, and extreme fatigue. However, bowel cancer can also develop with no symptoms until it has spread, making it far harder to treat. Worryingly, rates are rising among younger adults—defined in cancer terms as those under 50. A recent global study found cases are increasing in 27 of 50 countries. While bowel cancer is strongly linked to obesity, experts say it's increasingly affecting people who are otherwise fit and healthy. Some believe the answer lies in environmental exposures unique to younger generations. Although no single 'smoking gun' has been identified, theories include modern food additives, microplastics, and pollution. Around 44,000 cases of bowel cancer are diagnosed in the UK each year, with around 130,000 in the US. The disease claims nearly 17,000 lives annually in Britain and about 50,000 in America. Overall, just over half of patients survive for at least a decade after diagnosis. According to Cancer Research UK, 54 per cent of bowel cancer cases are preventable.


The Independent
26 minutes ago
- The Independent
NHS ‘invisible waiting list' as three million patients await specialist appointments
Three million patients in England have had no appointment after being referred by their GPs to specialist care, a new analysis has suggested. NHS England figures last month estimated 7.36 million treatments were waiting to be carried out at the end of May, relating to just under 6.23 million patients. The new analysis from MBI Health suggests almost half of those have been left in limbo. Delays in making a first assessment can lead to late diagnosis, worsening symptoms and pressure on emergency services. The Patients Association, which represents patients across the country, said if accurate, t he situation was 'staggering' and meant millions are waiting on an 'invisible waiting list.' The analysis comes after data showed the NHS is making progress in reducing the overall waiting list ahead of Sir Keir Starmer 's promise for 92 per cent of patients to be treated within 18 weeks by March 2029 - a target not met since 2015. MBI's analysis found that around 70 per cent of referral to treatment pathways fall into the category of being 'unseen' since the patient's GP referred them to a specialist. The latest figures show how challenging that target will be, given an estimated one million of the three million unseen patients have already gone more than 18 weeks without receiving any care. The analysis found that ear, nose and throat (ENT), trauma and orthopaedics, gastroenterology, ophthalmology and gynaecology and obstetrics departments were consistently the specialist departments with the greatest number of patients not seen for the first time. Rachel Power, the chief executive of the Patients Association, told the Guardian 'If accurate, three million people are trapped in an invisible waiting list crisis, stuck without basic diagnostic tests of first appointments while their conditions worsen,' 'The scale is staggering, as nearly half of all patients on a waiting list haven't been seen by anyone. That's not a healthcare service; that's a breakdown. 'These aren't just statistics. They're people checking their phones daily for hospital calls that never come, unable to plan their lives while their symptoms deteriorate.' Last month, figures showed 56.1 per cent of those on the list at the end of June this year were of working age (defined as age 19 to 64), up from 55.8 per cent a year ago and 55 per cent in June 2022. At the same time, the proportion of people on the waiting list under the age of 19 has fallen, standing at 10.8 per cent in June this year, down from 11.2 per cent a year earlier and 11.9 per cent in June 2022. The proportion who are over 65 has remained broadly unchanged at around 33.1 per cent. The Department of Health and Social Care (DHSC) said: 'Thanks to this government's record investment, reforms and the hard work of NHS staff, we've cut the waiting list by over 260,000 since July 2024, which also fell for the first time in 17 years in April and May outside the pandemic. On top of this, we have also delivered 4.6m appointments – more than double the 2m we promised. 'This government is delivering the fundamental reform needed to turn our NHS around, and our 10-year health plan will build on this progress, to ensure we meet our target that 92 per cent of patients wait no longer than 18 weeks for treatment by March 2029.'


STV News
26 minutes ago
- STV News
I won't ever sit back and declare ‘job done', says drugs minister
Drugs minister Maree Todd has said she will never 'sit back, relax and say 'job done'' in the fight against drug deaths. Todd was appointed to the role in June following the death of Christina McKelvie earlier this year from secondary breast cancer. Despite the circumstances of the appointment, the former mental health pharmacist said she was 'excited' to move from the social care brief to drugs as the Government continues its push to tackle the level of addiction and death across Scotland. The minister inherits a legacy which has been long-criticised by opponents, with Scotland having the highest drug death rates in Europe – a figure which actually increased between 2022 and 2023 in the latest available confirmed data. Just this week, figures showed the number of suspected drug deaths between March and May of this year increased by 15% compared to the previous 13 weeks. Speaking to the PA news agency, the minister said there is a 'consensus' that 'the work we are doing is the right kind of work', but the Government is responding to a 'changing landscape'. When the Government launched its national mission on drugs under the premiership of Nicola Sturgeon, the focus was largely on opioids such as heroin. But that has shifted, reflecting an increase in the injection of cocaine and the spectre of synthetic opioids known as nitazenes. On the latter, the minister said: 'They are unbelievably potent, super-strong, very tiny amounts can cause fatal overdoses easily.' As it looks to deal with the shifting threat posed by drugs, she stressed the need for the Government to be 'agile'. Todd said: 'We've just had our rapid action drug alerts and response (Radar) statistics released this week and we've seen a rise in deaths, a rise in Naloxone use, a rise in hospital admissions. 'We are seeing some absolutely significant and tangible harm occurring because of the change in the drug supply. 'I suppose the lesson that provides to me is that we need to be agile. 'I don't think we do one thing and this job is done and we fixed the problem that Scotland faces, we have to continually look carefully at what's happening in Scotland, understand the challenges that we're facing, understand the harms that people are experiencing.' She added: 'I don't think I would ever sit back and relax and say 'job done'. 'I think we've seen some significant progress, but each of these deaths is an absolute tragedy – it's a family who's lost a loved one, it's a loss of potential and contribution to our communities.' The way forward, she said , is a job for the whole of Government, saying there is a need for 'primary prevention'. The minister said: 'We need to be thinking, why is it that Scotland faces this challenge and what can we do to shift the likelihood that people growing up in Scotland will turn to drugs and alcohol as they grow older?' Earlier this year, the Thistle Centre opened in the east end of Glasgow, a UK-first safe consumption room giving those struggling with addiction a safe place to inject drugs. Since opening, the facility has supervised 3,008 injecting episodes and dealt with 39 medical emergencies, which could include administering Naloxone or even resuscitation. 'People would definitely have died if they had not been in that unit,' Ms Todd said. 'I think in March, there was a cluster of very profound overdose episodes, I think this is the issue with nitazenes, they act very fast, so people were really unwell really quickly and it takes a lot of Naloxone because of its potency.' In other parts of Scotland without the benefit of a safe consumption room where that specific batch of drug was used, the minister said: 'Where people used it, they did die.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country